StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLN) stock

STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.40−0.14 (-3.95%)

Close on Nov 17, 2026Market cap $346.52MP/E –Yield –

Starling Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Starling Oncology's price to book ratio was 64.4× on Jul 31, 2025, against 1.0× a year earlier. Over the last 5 years it ranged from 0.3× to 64.4×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 202564.4×+62.9
2024Dec 31, 20241.5×−0.6
2023Dec 29, 20232.1×+1.2
2022Dec 30, 20220.9×−3.8
2021Dec 31, 20214.7×–

More Starling Oncology figures

See a number that looks wrong?